FDA Explains Expectations For Drugmakers' Data Retention
The U.S. Food and Drug Administration answered drugmakers' questions Wednesday about how to maintain data from drug tests and the manufacturing floor, following an uptick in violations of federal information retention...To view the full article, register now.
Already a subscriber? Click here to view full article